Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, June 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 18,822 followers.

RT @aarc_tweets: Is it time to phase out ICS and switch to the new LAMA/LABA inhalers? What do you think, RTs? https://t.co/CDe5JokZ6p

RT @aarc_tweets: Is it time to phase out ICS and switch to the new LAMA/LABA inhalers? What do you think, RTs? https://t.co/CDe5JokZ6p

RT @aarc_tweets: Is it time to phase out ICS and switch to the new LAMA/LABA inhalers? What do you think, RTs? https://t.co/CDe5JokZ6p

Is it time to phase out ICS and switch to the new LAMA/LABA inhalers? What do you think, RTs? https://t.co/CDe5JokZ6p

RT @StLouisResearch: Maintenance therapy in COPD: time to phase out ICS and switch to the | COPD @DovePress https://t.co/FBVTLZsYu3

Maintenance therapy in COPD: time to phase out ICS and switch to the | COPD @DovePress https://t.co/FBVTLZsYu3